Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization.

Primary cutaneous B-cell lymphomas (PCBLs) may have particular clinicopathologic characteristics distinct from their lymph node-based counterparts. It has been suggested that PCBLs should have a separate classification system. The aim of this study was to determine whether the Revised European-American Lymphoid Neoplasms (REAL) classification is applicable to PCBL. Thirty-nine cases of PCBL from 36 patients, consisting of 20 men and 16 women (median age 66 yrs), were included in this study. Paraffin-section immunohistochemistry for CD3, CD5, CD10, CD20, CD43, Bcl-2, Bcl-6, and cyclin D1 was performed in all cases. Immunostaining for immunoglobulin light chains was also performed on cases histologically diagnosed as extranodal marginal zone lymphoma (MZL) and primary cutaneous B-cell lymphoma unclassifiable (PCBLu). Polymerase chain reaction (PCR) analysis of t(14;18) was performed in all cases. Immunoglobulin heavy chain gene rearrangement (VDJ) was tested by PCR on all follicle center lymphoma (FCL), MZL, and PCBLu cases. The 39 cases consisted of 15 (39%) FCLs, 13 (33%) diffuse large B-cell lymphomas (DLCL), 9 (23%) extranodal MZL, and 2 cases of PCBLu. Anatomically, 59% of PCBLs occurred in the head and neck, of which approximately 57% were FCL. Five of six cases presenting on the lower extremity were DLCL. Follow-up data was available from all 39 patients with a mean of 50.8 months. All but two patients are alive with or without disease at last contact. One patient with DLCL died of lung metastases and the other DLCL patient died of sepsis as a complication of therapy. In all 15 cases of FCL, CD10 and/or Bcl-6 expression supported the follicle center origin of the neoplastic cells. In contrast to previous reports, we found that 53% (8 of 15) of primary cutaneous FCL had either Bcl-2 protein expression or t(14;18). Our data indicate that many cases of primary cutaneous FCL have Bcl-2 alterations similar to their nodal counterpart. We found that 95% (37 of 39) of PCBLs could be classified according to the REAL classification, supporting its applicability in cutaneous lymphomas.

[1]  S. Alkan,et al.  Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders. , 1999, American journal of clinical pathology.

[2]  C. Meijer,et al.  EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. , 1999, The American Journal of dermatopathology.

[3]  N. Harris,et al.  Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. , 1999, The American journal of surgical pathology.

[4]  R. Russell‐Jones,et al.  Primary cutaneous B‐cell lymphoma: how useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification? , 1998, The British journal of dermatology.

[5]  J. K. Chun,et al.  Is the REAL Classification for Real? Do We Need a Separate Classification for Cutaneous Lymphomas? , 1997 .

[6]  H. Kerl,et al.  Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. , 1997, The American journal of surgical pathology.

[7]  B. Dréno,et al.  Primary cutaneous lymphomas: a study of 37 cases , 1997, International journal of dermatology.

[8]  E. Jaffe,et al.  The Revised European‐American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas , 1997, Journal of cutaneous pathology.

[9]  H. Kerl,et al.  EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.

[10]  M. Spanjer.  Changes suggested in Dutch system of reporting euthanasia and assisted suicide. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  S. Pileri,et al.  Bcl-6 protein expression in normal and neoplastic lymphoid tissues. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  R. Willemze,et al.  Primary Cutaneous Large B-Cell Lymphomas of the Legs: A Distinct Type of Cutaneous B-Cell Lymphoma With an Intermediate Prognosis , 1996 .

[13]  R. Willemze,et al.  Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group. , 1996, Archives of dermatology.

[14]  S. M. Svoboda-Newman,et al.  Comparison of Methods for Extracting DNA from Formalin‐Fixed Paraffin Sections for Nonisotopic PCR , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[15]  E. Noordijk,et al.  Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  P. Isaacson,et al.  A comparative study of the value of immunohistochemistry and the polymerase chain reaction in the diagnosis of follicular lymphoma , 1995, Histopathology.

[17]  K. Offit,et al.  BCL-6 protein is expressed in germinal-center B cells. , 1995, Blood.

[18]  M. Wick,et al.  Immunoreactivity for bcl‐2 protein in cutaneous lymphomas and lymphoid hyperplasias * , 1995 .

[19]  R. Osamura,et al.  Antigen retrieval for bcl‐2 protein in formalin‐fixed, paraffin‐embedded sections , 1995, Pathology international.

[20]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[21]  R. Braylan,et al.  Standard polymerase chain reaction analysis does not detect t(14;18) in reactive lymphoid hyperplasia. , 1994, Archives of pathology & laboratory medicine.

[22]  H. Kerl,et al.  bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. , 1994, The Journal of investigative dermatology.

[23]  R. Willemze,et al.  Primary cutaneous B-cell lymphomas. , 1994, Leukemia & lymphoma.

[24]  C. Meijer,et al.  Classification of primary cutaneous lymphomas. Historical overview and perspectives. , 1994, Dermatology.

[25]  H. Kerl,et al.  Cutaneous immunocytomas: a clinicopathologic study of 26 cases , 1993, Histopathology.

[26]  M. Stoler,et al.  Identification of monoclonal B-cell populations by rapid cycle polymerase chain reaction. A practical screening method for the detection of immunoglobulin gene rearrangements. , 1992, The American journal of pathology.

[27]  H. Kerl,et al.  Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction , 1992, Journal of cutaneous pathology.

[28]  P. Gaulard,et al.  Expression of the bcl-2 gene product in follicular lymphoma. , 1992, The American journal of pathology.

[29]  N. Pimpinelli,et al.  Primary cutaneous B‐cell lymphoma: A unique type of low‐grade lymphoma. Clinicopathologic and immunologic study of 83 cases , 1991, Cancer.

[30]  A. Morley,et al.  Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. , 1990, Journal of clinical pathology.

[31]  D. Mason,et al.  The 14;18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction , 1990, British journal of haematology.

[32]  M. Borrello,et al.  Clonal immunoglobulin gene rearrangements and normal T-cell receptor, bcl-2, and c-myc genes in primary cutaneous B-cell lymphomas. , 1989, Cancer research.

[33]  K. Lennert,et al.  Updated Kiel classification for lymphomas , 1989, The Journal of pathology.

[34]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue , 1987, Histopathology.

[35]  H. Levine,et al.  Uniform detection of immunoglobulin-gene rearrangement in benign lymphoepithelial lesions. , 1987, The New England journal of medicine.

[36]  C. Meijer,et al.  Diffuse large cell lymphomas of follicular center cell origin presenting in the skin. A clinicopathologic and immunologic study of 16 patients. , 1987, The American journal of pathology.

[37]  R. Warnke,et al.  Cutaneous Follicular Lymphoma , 1986, The American journal of surgical pathology.

[38]  O. Braun-falco,et al.  Cutaneous B-cell lymphoma. , 1985, Dermatologic clinics.

[39]  R B Mann,et al.  Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative method , 2007, Hematological oncology.

[40]  R. Warnke,et al.  The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides. , 1983, Blood.